October 12, 2015

Specialty Pharmacy Times — Over the past decade, the sharp increase in spending for specialty medications has led payers to scrutinize new, high-cost therapies and question their clinical benefits and return on investment. Estimates suggest specialty spending will rise from $290 per member per year (PMPY) in 2012 to $845 PMPY by 2018.1 Numerous organizations have suggested that specialty prescriptions, which typically represent approximately 1% of pharmacy claims, will represent 50% of the total drug spend within the next few years.